These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 33610563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ, Huang LZ, Zhou AY, Zhao M, Yu WZ, Li XX.
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
    Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett ME.
    Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
    [Abstract] [Full Text] [Related]

  • 5. CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo.
    Zhang K, Wang L, Wei A, Jia X, Liu X.
    Thorac Cancer; 2020 Jun; 11(6):1566-1577. PubMed ID: 32368855
    [Abstract] [Full Text] [Related]

  • 6. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
    Joe SG, Yoon YH, Choi JA, Koh JY.
    PLoS One; 2015 Jun; 10(3):e0119708. PubMed ID: 25785990
    [Abstract] [Full Text] [Related]

  • 7. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F, Bai Y, Yu W, Han N, Huang L, Zhao M, Zhou A, Zhao M, Li X.
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
    [Abstract] [Full Text] [Related]

  • 8. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL, Suh W.
    Invest Ophthalmol Vis Sci; 2017 Jul 01; 58(9):3592-3599. PubMed ID: 28715845
    [Abstract] [Full Text] [Related]

  • 9. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W, Tu H, Zhu Y, Guan Y, Liu H, Ling W, Yan P, Dong J.
    Phytomedicine; 2019 Nov 01; 64():152923. PubMed ID: 31450226
    [Abstract] [Full Text] [Related]

  • 10. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X, Wu L, Zhou X, Zhou N, Zhuang Q, Yang J, Dai J, Wang H, Chen S, Mao W.
    Microvasc Res; 2017 May 01; 111():25-31. PubMed ID: 28040437
    [Abstract] [Full Text] [Related]

  • 11. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
    Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ.
    World J Gastroenterol; 2015 Aug 28; 21(32):9566-76. PubMed ID: 26327764
    [Abstract] [Full Text] [Related]

  • 12. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
    Wang H, Yang Z, Jiang Y, Hartnett ME.
    Mol Vis; 2014 Aug 28; 20():231-41. PubMed ID: 24623966
    [Abstract] [Full Text] [Related]

  • 13. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y, Zhao M, Zhang C, Li S, Qi Y, Wang B, Huang L, Li X.
    PLoS One; 2014 Aug 28; 9(11):e112448. PubMed ID: 25380141
    [Abstract] [Full Text] [Related]

  • 14. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S, Chikaraishi Y, Tsuruma K, Shimazawa M, Hara H.
    Exp Eye Res; 2010 Jan 28; 90(1):137-45. PubMed ID: 19825373
    [Abstract] [Full Text] [Related]

  • 15. A Novel Hypoxia-inducible Factor 1α Inhibitor KC7F2 Attenuates Oxygen-induced Retinal Neovascularization.
    Tang X, Cui K, Lu X, Wu P, Yu S, Yang B, Xu Y, Liang X.
    Invest Ophthalmol Vis Sci; 2022 Jun 01; 63(6):13. PubMed ID: 35695808
    [Abstract] [Full Text] [Related]

  • 16. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 01; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 17. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S, Kanaujia PK, Kumar S, Kumar R, Alhaider AA.
    Mol Cancer; 2013 Jul 29; 12():82. PubMed ID: 23895055
    [Abstract] [Full Text] [Related]

  • 18. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D, Xie K, Zhang L, Yao X, Li H, Xu Q, Wang X, Jiang J, Fang J.
    Cancer Lett; 2016 Jul 28; 377(2):164-73. PubMed ID: 27130666
    [Abstract] [Full Text] [Related]

  • 19. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC, Chung CL, Huang TF, Chang TC, Chen KC, Gao GY, Hsu MJ, Huang SW.
    Br J Pharmacol; 2019 Oct 28; 176(20):4034-4049. PubMed ID: 31368127
    [Abstract] [Full Text] [Related]

  • 20. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.